Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.

Journal of experimental & clinical cancer research : CR - 6 Aug 2014

Kanda Mitsuro, Nomoto Shuji, Oya Hisaharu, Shimizu Dai, Takami Hideki, Hibino Soki, Hashimoto Ryoji, Kobayashi Daisuke, Tanaka Chie, Yamada Suguru, Fujii Tsutomu, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

Abstract excerpt

BACKGROUND: Gastric cancer (GC) remains to have a poor prognosis via diverse process of cancer progression. Dihydropyrimidinase-like 3 (DPYSL3) is a cell adhesion molecule that has been reported to be involved in the metastatic process of tumor cells. The aim of this study was to identify a novel clinically-relevant biomarker of GC. METHODS: Expression analysis of DPYSL3 mRNA and protein levels was conducted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Muscle Proteins

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Stomach Neoplasms

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 25096402
DOI: 10.1186/s13046-014-0066-9
PMCID: PMC4431488

Genes

DPYSL3
EZR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.PMID 25096402Read ↗

PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic CharacteristicsSemantic proximity Read ↗

Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal DisseminationSemantic proximity Read ↗

Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancerSemantic proximity Read ↗

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancerSemantic proximity Read ↗

Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancerSemantic proximity Read ↗

CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltrationSemantic proximity Read ↗

GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GCSemantic proximity Read ↗

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancerSemantic proximity Read ↗

PLCD3 inhibits apoptosis and promotes proliferation, invasion and migration in gastric cancerSemantic proximity Read ↗

STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future ProspectsSemantic proximity Read ↗

MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathwaySemantic proximity Read ↗

The E2F3/miR-125a/DKK3 regulatory axis promotes the development and progression of gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.